Abstract
In this chapter, two important placenta-associated pregnancy syndromes are described: preeclampsia and fetal growth restriction/intra-uterine growth restriction (FGR/IUGR). For both disorders, the sequences of development are still largely unclear. Therefore, the first section attempts to summarize the current hypotheses on the development of both syndromes and to contrast them with the old hypotheses. The decisive role of the interplay between mother and placenta becomes apparent. The second section covers the diagnosis and management of fetal growth restriction and what major studies are currently underway to determine the best care for the child. The final section covers the diagnosis and management of preeclampsia. This also includes information on predictive biomarkers, risk assessment in the first trimester, and long-term illnesses due to preeclampsia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Section 11.1
Bahlmann F, Fittschen M, Reinhard I, Wellek S, Steiner E (2012) Reference values for blood flow velocity in the uterine artery in normal pregnancies from 18 weeks to 42 weeks of gestation calculated by automatic Doppler waveform analysis. Ultraschall Med 33:258–264
Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30:473–482
Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, Cuckle H, Wolf M (2007) First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 197:35.e1–35.e7
Choudhury M, Friedman JE (2012) Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens 34:334–341
von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. Hypertens Pregnancy 22:143–148
Davey DA, MacGillivray I (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898
Douglas KA, Redman CW (1994) Eclampsia in the United Kingdom. BMJ 309:1395–1400
von Ehr J, von Versen-Höynck F (2016) Implications of maternal conditions and pregnancy course on offspring’s medical problems in adult life. Arch Gynecol Obstet 294:673–679
Godfrey KM, Barker DJ (2001) Fetal programming and adult health. Pub Health Nutr 4:611–624
Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, von Dadelszen P (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27:56–61
Hogg K, Blair JD, McFadden DE, von Dadelszen P, Robinson WP (2013) Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta. PLoS 8:e62969
Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51:970–975
Huppertz B (2010) IFPA Award in Placentology Lecture: biology of the placental syncytiotrophoblast–myths and facts. Placenta 31(Suppl):75–81
Huppertz B (2011) Trophoblast differentiation, fetal growth restriction and preeclampsia. Pregnancy Hypertens 1:79–86
Huppertz B, Kadyrov M, Kingdom JC (2006) Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 195:29–39
Huppertz B, Gauster M, Orendi K, König J, Moser G (2009) Oxygen as modulator of trophoblast invasion. J Anat 215:14–20
Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H (2008) Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 24:230–236
Irgens HU, Reisaeter L, Irgens LM, Lie RT (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323:1213–1217
Jauniaux E, Greenwold N, Hempstock J, Burton GJ (2003) Comparison of ultrasonographic and doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril 79:100–106
Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ (2000) Onset of maternal arterial blood flow and placental oxidative stress; a possible factor in human early pregnancy failure. Am J Pathol 157:2111–2122
Johansen M, Redman CW, Wilkins T, Sargent IL (1999) Trophoblast deportation in human pregnancy – its relevance for pre-eclampsia. Placenta 20:531–539
Kakogawa J, Sumimoto K, Kawamura T, Minoura S, Kanayama N (2010) Noninvasive monitoring of placental oxygenation by near-infrared spectroscopy. Am J Perinatol 27:463–468
Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7
Kawamura T, Kakogawa J, Takeuchi Y, Takani S, Kimura S, Nishiguchi T, Sugimura M, Sumimoto K, Kanayama N (2007) Measurement of placental oxygenation by transabdominal near-infrared spectroscopy. Am J Perinatol 24:161–166
Kingdom JC, Kaufmann P (1997) Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18:613–621
Konje JC, Kaufmann P, Bell SC, Taylor DJ (2001) A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am J Obstet Gynecol 185:608–613
Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, Clemens JD, Cutler JA (1997) Trial of calcium to prevent preeclampsia. N Engl J Med 337:69–76
Lindheimer MD, Taler SJ, Cunningham FG, American Society of Hypertension (2009) ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich) 11:214–225
Longtine MS, Nelson DM (2011) Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition. Semin Reprod Med 29:187–196
MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538
Mongraw-Chaffin ML, Cirillo PM, Cohn BA (2010) Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 56:166–171
Moodley J, Kalane G (2006) A review of the management of eclampsia: practical issues. Hypertens Pregnancy 25:47–62
Myatt L, Miodovnik M (1999) Prediction of preeclampsia. Semin Perinatol 25:45–57
Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS (2006) A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 27:13–17
Pijnenborg R, Vercruysse L, Hanssens M (2006) The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27:939–958
Pilalis A, Souka AP, Antsaklis P, Basayiannis K, Benardis P, Haidopoulos D, Papantoniou N, Mesogitis S, Antsaklis A (2007) Screening for pre-eclampsia and small for gestational age fetuses at the 11–14 weeks scan by uterine artery Dopplers. Acta Obstet Gynecol Scand 86:530–534
Redman CW, Sargent IL (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta 21:597–602
Roberts JM, Cooper DW (2001) Pathogenesis and genetics of preeclampsia. Lancet 357:53–56
Rodesch F, Simon P, Donner C, Jauniaux E (1992) Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 80:283–285
Schaaps JP, Tsatsaris V, Goffin F, Brichant JF, Delbecque K, Tebache M, Collignon L, Retz MC, Foidart JM (2005) Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol 192:323–332
Schaarschmidt W, Rana S, Stepan H (2013) The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med 41:511–516
Sibai BM (1990) Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049–1054
Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103:981–991
Sibai BN, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R (1993) Prevention of preeclampsia with low-dose aspirin in health. Nulliparous pregnant women. N Engl J Med 329:1213–1218
Sibley CP, Pardi G, Cetin I, Todros T, Piccoli E, Kaufmann P, Huppertz B, Bulfamante G, Cribiu FM, Ayuk P, Glazier J, Radaelli T (2002) Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project ‘Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies’ − a workshop report. Placenta 23(Suppl A):75–79
Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357:2002–2006
Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA (2009) Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol 29:680–684
Walker JJ (2000) Preeclampsia. Lancet 356:1260–1265
Section 11.2
Arabin B, Siebert M, Jimenez E, Saling E (1988) Obstetrical characteristics of a loss of end-diastolic velocities in the fetal aorta and/or umbilical artery using Doppler ultrasound. Gynecol Obstet Invest 25:173–180
Arbeille P, Maulik D, Fignon A et al (1995) Assessment of the fetal PO2 changes by cerebral and umbilical Doppler on lamb fetuses during acute hypoxia. Ultrasound Med Biol 21:861–870
Aucott SW, Donohue PK, Northington FJ (2004) Increased morbidity in severe early intrauterine growth restriction. J Perinatol 24:435–440. https://doi.org/10.1038/sj.jp.7211116
Baschat A (2013) Fetale Wachstumsrestriktion. Ultraschalldiagnostik in Geburtshilfe und Gynäkologie. Springer, Berlin, pp 519–539
Baschat AA (2011) Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 37:501–514. https://doi.org/10.1002/uog.9008
Baschat AA, Cosmi E, Bilardo CM et al (2007) Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 109:253–261. https://doi.org/10.1097/01.aog.0000253215.79121.75
Blair EM, Nelson KB (2015) Fetal growth restriction and risk of cerebral palsy in singletons born after at least 35 weeks’ gestation. Am J Obstet Gynecol 212:520.e1–520.e7. https://doi.org/10.1016/j.ajog.2014.10.1103
Boers KE, Vijgen SMC, Bijlenga D et al (2010) Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 341:c7087–c7087. https://doi.org/10.1136/bmj.c7087
Butt K, Lim K, Society of Obstetricians and Gynaecologists of Canada (2014) Determination of gestational age by ultrasound. J Obstet Gynaecol Can 36:171–183
Campbell S, Thoms A (1977) Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obs Gynaecol 84:165–174
Chauhan SP, Taylor M, Shields D et al (2007) Intrauterine growth restriction and oligohydramnios among high-risk patients. Am J Perinatol 24:215–221
Cianfarani S, Agostoni C, Bedogni G et al (2012) Effect of intrauterine growth retardation on liver and long-term metabolic risk. Int J Obes (Lond) 36:1270–1277. https://doi.org/10.1038/ijo.2012.54
Dashe JS, McIntire DD, Lucas MJ, Leveno KJ (2000) Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 96:321–327
DeVore GR (2015) The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol 213:5–15. https://doi.org/10.1016/j.ajog.2015.05.024
Divon MY, Chamberlain PF, Sipos L et al (1986) Identification of the small for gestational age fetus with the use of gestational age-independent indices of fetal growth. Am J Obstet Gynecol 155:1197–1201
Ferrazzi E, Bozzo M, Rigano S et al (2002) Temporal sequence of abnormal doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 19:140–146. https://doi.org/10.1046/j.0960-7692.2002.00627.x
Flood K, Unterscheider J, Daly S et al (2014) The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study. Am J Obstet Gynecol 211:288.e1–288.e5. https://doi.org/10.1016/j.ajog.2014.05.008
Frøen JF, Heazell AEP, Tveit JVH et al (2008) Fetal movement assessment. Semin Perinatol 32:243–246. https://doi.org/10.1053/j.semperi.2008.04.004
Gardosi J, Clausson B, Francis A (2009) The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size. BJOG 116:1356–1363. https://doi.org/10.1111/j.1471-0528.2009.02245.x
Gardosi J, Giddings S, Buller S et al (2014) Preventing stillbirths through improved antenatal recognition of pregnancies at risk due to fetal growth restriction. Public Health 128:698–702. https://doi.org/10.1016/j.puhe.2014.06.022
Gardosi J, Madurasinghe V, Williams M et al (2013) Maternal and fetal risk factors for stillbirth: population based study. BMJ 346:f108–f108. https://doi.org/10.1136/bmj.f108
Gembruch U, Hecher K, Steiner H (2013) Prädiktiver Ultraschall für Präeklampsie und intrauterine Wachstumsretardierung im II. Trimenon. In: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie. Springer, Berlin, pp 467–478
Getahun D, Ananth CV, Kinzler WL (2007) Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynecol 196:499–507. https://doi.org/10.1016/j.ajog.2006.09.017
Hadlock FP, Harrist RB, Sharman RS et al (1985) Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obs Gynecol 151:333–337
Haugen G, Kiserud T, Godfrey K et al (2004) Portal and umbilical venous blood supply to the liver in the human fetus near term. Ultrasound Obstet Gynecol 24:599–605. https://doi.org/10.1002/uog.1744
Hay WW (2006) Recent observations on the regulation of fetal metabolism by glucose. J Physiol 572:17–24. https://doi.org/10.1113/jphysiol.2006.105072
Hofstaetter C, Gudmundsson S, Hansmann M (2002) Venous doppler velocimetry in the surveillance of severely compromised fetuses. Ultrasound Obstet Gynecol 20:233–239. https://doi.org/10.1046/j.1469-0705.2002.00791.x
Hübner J, Gast A-S, Müller AM et al (2015) Stillbirths in Germany: retrospective analysis of 168 cases between 2003 and 2011. Z Geburtshilfe Neonatol 219:73–80. https://doi.org/10.1055/s-0034-1395654
Jarvis S, Glinianaia SV, Torrioli M-G et al (2003) Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 362:1106–1111. https://doi.org/10.1016/s0140-6736(03)14466-2
de Jong CL, Francis A, van Geijn HP, Gardosi J (1999) Fetal growth rate and adverse perinatal events. Ultrasound Obstet Gynecol 13:86–89. https://doi.org/10.1046/j.1469-0705.1999.13020086.x
Khalil AA, Morales-Rosello J, Elsaddig M et al (2015) The association between fetal doppler and admission to neonatal unit at term. Am J Obstet Gynecol 213:57.e1–57.e7. https://doi.org/10.1016/j.ajog.2014.10.013
Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ (1988) Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 82:83–90
Kiserud T, Kessler J, Ebbing C, Rasmussen S (2006) Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 28:143–149. https://doi.org/10.1002/uog.2784
Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P (2003) International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, april 24-October 1, 2001. Pediatrics 111:1253–1261
Lees C, Marlow N, Arabin B et al (2013) Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 42:400–408. https://doi.org/10.1002/uog.13190
Lees CC, Marlow N, van Wassenaer-Leemhuis A et al (2015) 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 385:2162–2172. https://doi.org/10.1016/s0140-6736(14)62049-3
Longo S, Borghesi A, Tzialla C, Stronati M (2014) IUGR and infections. Early Hum Dev 90(1):S42–S44. https://doi.org/10.1016/s0378-3782(14)70014-3
Lunde A, Melve KK, Gjessing HK et al (2007) Genetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parent-offspring data. Am J Epidemiol 165:734–741. https://doi.org/10.1093/aje/kwk107
Manning FA (2002) Fetal biophysical profile: a critical appraisal. Clin Obstet Gynecol 45:975–985
McIntire DD, Bloom SL, Casey BM, Leveno KJ (1999) Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 340:1234–1238. https://doi.org/10.1056/nejm199904223401603
Meher S, Hernandez-Andrade E, Basheer SN, Lees C (2015) Impact of cerebral redistribution on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: a systematic review. Ultrasound Obstet Gynecol 46:398–404. https://doi.org/10.1002/uog.14818
Mongelli M, Ek S, Tambyrajia R (1998) Screening for fetal growth restriction: a mathematical model of the effect of time interval and ultrasound error. Obs Gynecol 92:908–912
Morrow RJ, Adamson SL, Bull SB, Ritchie JW (1989) Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep. Am J Obstet Gynecol 161:1055–1060
Nicolaides KH, Peters MT, Vyas S et al (1990) Relation of rate of urine production to oxygen tension in small-for-gestational-age fetuses. Am J Obstet Gynecol 162:387–391
Ott WJ (1988) The diagnosis of altered fetal growth. Obstet Gynecol Clin North Am 15:237–263
Ott WJ (1990) Comparison of dynamic image and pulsed Doppler ultrasonography for the diagnosis of intrauterine growth retardation. J Clin Ultrasound 18:3–7
Parra-Saavedra M, Crovetto F, Triunfo S et al (2014) Association of Doppler parameters with placental signs of underperfusion in late-onset small-for-gestational-age pregnancies. Ultrasound Obstet Gynecol 44:330–337. https://doi.org/10.1002/uog.13358
Pecks U, Brieger M, Schiessl B et al (2012) Maternal and fetal cord blood lipids in intrauterine growth restriction. J Perinat Med 40:287–296. https://doi.org/10.1515/jpm.2011.135
Pecks U, Kirschner I, Wölter M et al (2014) Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals. Transl Res 164:57–69. https://doi.org/10.1016/j.trsl.2013.12.003
Pecks U, Rath W, Maass N et al (2016) Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction. Lipids Health Dis 15:193. https://doi.org/10.1186/s12944-016-0365-6
Pike K, Jane Pillow J, Lucas JS (2012) Long term respiratory consequences of intrauterine growth restriction. Semin Fetal Neonatal Med 17:92–98. https://doi.org/10.1016/j.siny.2012.01.003
Pilliod RA, Cheng YW, Snowden JM et al (2012) The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol 207:318.e1–318.e6. https://doi.org/10.1016/j.ajog.2012.06.039
Roma E, Arnau A, Berdala R et al (2015) Ultrasound screening for fetal growth restriction at 36 vs 32 weeks’ gestation: a randomized trial (ROUTE). Ultrasound Obstet Gynecol 46:391–397. https://doi.org/10.1002/uog.14915
Savchev S, Figueras F, Sanz-Cortes M et al (2014) Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction. Fetal Diagn Ther 36:99–105. https://doi.org/10.1159/000355525
Sheth T, Glantz JC (2016) Third-trimester fetal biometry and neonatal outcomes in term and preterm deliveries. J Ultrasound Med 35:103–110. https://doi.org/10.7863/ultra.15.02040
Simon NV, O’Connor TJ, Shearer DM (1990) Detection of intrauterine fetal growth retardation with abdominal circumference and estimated fetal weight using cross-sectional growth curves. J Clin Ultrasound 18:685–690
Stampalija T, Arabin B, Wolf H et al (2017) Is middle cerebral artery doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? Am J Obstet Gynecol. 216:521.e1–521.e13. https://doi.org/10.1016/j.ajog.2017.01.001
Svensson AC, Pawitan Y, Cnattingius S et al (2006) Familial aggregation of small-for-gestational-age births: the importance of fetal genetic effects. Am J Obstet Gynecol 194:475–479. https://doi.org/10.1016/j.ajog.2005.08.019
Thornton JG, Hornbuckle J, Vail A et al (2004) Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 364:513–520. https://doi.org/10.1016/s0140-6736(04)16809-8
Torrance HL, Bloemen MCT, Mulder EJH et al (2010) Predictors of outcome at 2 years of age after early intrauterine growth restriction. Ultrasound Obstet Gynecol 36:171–177. https://doi.org/10.1002/uog.7627
Turan OM, Turan S, Gungor S et al (2008) Progression of doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 32:160–167. https://doi.org/10.1002/uog.5386
Tyson JE, Parikh NA, Langer J et al (2008) Intensive care for extreme prematurity – moving beyond gestational age. N Engl J Med 358:1672–1681. https://doi.org/10.1056/nejmoa073059
Unterscheider J, Daly S, Geary MP et al (2013a) Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 208:290.e1–290.e6. https://doi.org/10.1016/j.ajog.2013.02.007
Unterscheider J, Daly S, Geary MP et al (2013b) Predictable progressive Doppler deterioration in IUGR: does it really exist? Am J Obstet Gynecol 209:539.e1–539.e7. https://doi.org/10.1016/j.ajog.2013.08.039
Van den Berg BJ, Yerushalmy J (1966) The relationship of the rate of intrauterine growth of infants of low birth weight to mortality, morbidity, and congenital anomalies. J Pediatr 69:531–545
Vergani P, Roncaglia N, Locatelli A et al (2005) Antenatal predictors of neonatal outcome in fetal growth restriction with absent end-diastolic flow in the umbilical artery. Am J Obstet Gynecol 193:1213–1218. https://doi.org/10.1016/j.ajog.2005.07.032
Visser GHA, Bilardo C, Derks JB et al (2016) The TRUFFLE study; fetal monitoring indications for delivery in 310 IUGR infants with 2 year’s outcome delivered before 32 weeks of gestation. Ultrasound Obstet Gynecol. 50(3):347–352. https://doi.org/10.1002/uog.17361
Voigt M, Schneider KT, Jahrig K (1996) Analysis of a 1992 birth sample in Germany. 1: new percentile values of the body weight of newborn infants. Geburtsh Frauenheilk 56:550–558
Voigt M, Rochow N, Schneider KTM et al (2014) New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007−2011 from all 16 states of Germany. Z Geburtshilfe Neonatol 218:210–217. https://doi.org/10.1055/s-0034-1385857
Walker D-M, Marlow N, Upstone L et al (2011) The growth restriction intervention trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. Am J Obstet Gynecol 204:34.e1–34.e9. https://doi.org/10.1016/j.ajog.2010.09.019
van Wyk L, Boers KE, van der Post JAM et al (2012) Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial. Am J Obstet Gynecol 206:406.e1–406.e7. https://doi.org/10.1016/j.ajog.2012.02.003
Section 11.3
Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 31(1):66–74
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2014) Hypertensive Schwangerschaftserkrankungen: Diagnostik und Therapie. AWMF Register-Nr. 015-018, 28.01.2014 redaktionell überarbeitet. http://www.awmf.org/uploads/tx_szleitlinien/015-018l_S1_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2014-01.pdf. Accessed 29 Nov 2017
Chaiworapongsa T et al (2014) Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10:466–480
Costantine MM, Cleary K, Hebert MF, Ahmed MS, Brown LM, Ren Z, Easterling TR, Haas DM, Haneline LS, Caritis SN, Venkataramanan R, West H, D’Alton M, Hankins G (2016) Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Units Network. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol 214(6):720.e1–720.e17
Craici I, Wagner S, Garovic VD (2008) Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Therap Adv Cardiovasc Dis 2(4):249–259
Cruz MO et al (2012) What is the optimal time for delivery in women with gestational hypertension? Am J Obstet Gynecol 207:214.e1–214e.6
Dechend R et al (2004) AT1 receptor agonistic antibodies, hypertension, and preeclampsia. Semin Nephrol 24:571–579
Ferrer RL, Sibai BM, Multrow CD et al (2000) Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 96:849–860
Garovic VD, Hayman SR (2007) Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 3(11):613–622
Girouard J, Giguère Y, Moutquin JM et al (2007) Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 49(5):1056–1062
Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187:233–238
Hagmann H et al (2012) The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem 58:837–845
Helewa ME, Burrows RF, Smith J et al (1997) Report of the Canadian hypertension society consensus conference: 1. Definitions, evaluations and classification of hypertensive disorders in pregnancy. CMAJ 157:715
Lam C et al (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077–1085
Lefkou E, Mamopoulos A, Dagklis T, Vosnakis C, Rousso D, Girardi G (2016) Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J Clin Invest 126(8):2933–2940
Levine RJ et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683
Levine RJ et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992–1005
Lucas MJ, Leveno KJ, Cunnningham FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333:201
Mol BWJ et al (2016) Pre-eclampsia. Lancet 387:999–1011
Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH (2009) First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33(1):23–33
Roberts JM et al (2003) Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41:437–444
Rodie VA, Freeman DJ, Sattar N et al (2004) Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175:189–202
Rolnik DL, Wright D, Poon LC et al (2017) Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377(7):613–622
Schnettler WT et al (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG 120:1224–1232
Stepan H et al (2008) Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 198:175.e1–175.e6
Thadhani R, Solomon CG (2008) Preeclampsia – a glimpse into the future? N Engl J Med 359:858–860
Thadhani R, Kisner T, Hagmann H et al (2011) Pilot study of extracorporal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124:940–950
Thadhani R, Hagmann H, Schaarschmidt W et al (2016) Removal of soluble Fms-Like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27(3):903–913
Verlohren S, Dudenhausen JW (2009) Präeklampsie und hypertensive Schwangerschaftserkrankungen. Frauenheilkunde up2date 3:461–472
Verlohren S et al (2010) An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202:161.e1–161.e11
Verlohren S et al (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(1):58.e1–58.e8
Vikse BE, Irgens LM, Leivestad T et al (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359:800–809
Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T (2010) Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev: Sep 8(9):CD008148. https://doi.org/10.1002/14651858.CD008148.pub2
Zeisler H et al (2016) Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. NEJM 374:13
Zhou Y et al (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? Clin Invest 99:2152–2164
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer-Verlag GmbH Germany, part of Springer Nature
About this chapter
Cite this chapter
Huppertz, B., Pecks, U., Stepan, H. (2023). Placental Insufficiency/Placenta-Associated Diseases. In: Huppertz, B., Schleußner, E. (eds) The Placenta. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-66256-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-66256-4_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-66255-7
Online ISBN: 978-3-662-66256-4
eBook Packages: MedicineMedicine (R0)